FGFR1Mutations in Rosette-Forming Glioneuronal Tumors of the Fourth Ventricle-Reference-Cited by-同舟云学术

FGFR1Mutations in Rosette-Forming Glioneuronal Tumors of the Fourth Ventricle

Published:2014-06 Issue:6 Volume:73 Page:580-584
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Gessi Marco,Moneim Yasmin Abdel,Hammes Jennifer,Goschzik Tobias,Scholz Martin,Denkhaus Dorota,Waha Andreas,Pietsch Torsten

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://academic.oup.com/jnen/article-pdf/73/6/580/9564052/73-6-580.pdf

Reference13 articles.

1. Hainfellner JA Scheithauer BW Giangaspero F . Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN Ohgaki H Wiestler OD Cavenee WK , eds. WHO Classification of Tumours of the Central Nervous System, 4th ed. Lyon, France; IARC Press, 2007; 115–16

2. The 2007 WHO Classification of Nervous System Tumors: Newly Recognized Members of the Mixed Glioneuronal Group

3. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT)

4. Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications

5. Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A diverse landscape of FGFR alterations and co-mutations defines novel therapeutic strategies in pediatric low-grade gliomas;2024-08-28

2. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

3. Imaging of pediatric glioneuronal and neuronal tumors;Child's Nervous System;2024-07-03

4. Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults;CNS Oncology;2024-06-14

5. Genetics of neuronal and glioneuronal cancers;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024